[go: up one dir, main page]

AU2635599A - Use of prolactin inhibitors for the treatment of fertility problems in animal species - Google Patents

Use of prolactin inhibitors for the treatment of fertility problems in animal species

Info

Publication number
AU2635599A
AU2635599A AU26355/99A AU2635599A AU2635599A AU 2635599 A AU2635599 A AU 2635599A AU 26355/99 A AU26355/99 A AU 26355/99A AU 2635599 A AU2635599 A AU 2635599A AU 2635599 A AU2635599 A AU 2635599A
Authority
AU
Australia
Prior art keywords
treatment
animal species
fertility problems
prolactin inhibitors
prolactin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26355/99A
Inventor
Eugen Eigenmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2635599A publication Critical patent/AU2635599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26355/99A 1999-03-17 1999-03-17 Use of prolactin inhibitors for the treatment of fertility problems in animal species Abandoned AU2635599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/000448 WO2000054776A1 (en) 1999-03-17 1999-03-17 Use of prolactin inhibitors for the treatment of fertility problems in animal species

Publications (1)

Publication Number Publication Date
AU2635599A true AU2635599A (en) 2000-10-04

Family

ID=11004835

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26355/99A Abandoned AU2635599A (en) 1999-03-17 1999-03-17 Use of prolactin inhibitors for the treatment of fertility problems in animal species

Country Status (2)

Country Link
AU (1) AU2635599A (en)
WO (1) WO2000054776A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936710B1 (en) * 2008-10-07 2011-01-07 Ceva Sante Animale ANTIPROLACTINIC VETERINARY COMPOSITION FOR RUMINANTS
WO2019149775A1 (en) * 2018-01-30 2019-08-08 Ceva Sante Animale Veterinary antiprolactinic composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
DE2656344A1 (en) * 1975-12-23 1977-07-07 Sandoz Ag ERGOLIN DERIVATIVES, THEIR USE AND MANUFACTURING
EP0003286B1 (en) * 1978-01-20 1982-03-24 Sandoz Ag Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
IT1215261B (en) * 1985-04-05 1990-01-31 Poli Ind Chimica Spa PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.
EP0781774B1 (en) * 1995-12-08 2002-07-31 Takeda Chemical Industries, Ltd. Prolactin production inhibitory agents

Also Published As

Publication number Publication date
WO2000054776A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU2001288458A1 (en) Methods for processing animal tissues
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
IL139491A0 (en) Phthalazine derivatives as phosphodiesterase-4 inhibitors
IL146094A0 (en) Diaminothiazoles and their use for inhibiting protein kinases
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
WO2001028494A3 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
AU5326100A (en) Pharmaceutical compositions and methods for use
AU1101501A (en) Methods and compositions for treatment of keratoconus using protease inhibitors
AU6056500A (en) Process and composition for temporarily suppressing pain
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2001268233A1 (en) Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
AU6917400A (en) Use of 5-ht1b/1d agonists to treat otic pain
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU7545200A (en) Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors
AU1878201A (en) Composition for the treatment of damaged tissue
AU2635599A (en) Use of prolactin inhibitors for the treatment of fertility problems in animal species
AU2003286068A1 (en) Process for the treatment of pig manure and the use thereof
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU3356000A (en) L-arginine based formulations for treating diseases and methods of using same
WO2001044235A3 (en) Agents and methods for the treatment of proliferative diseases
AU2566201A (en) Compounds and methods for the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase